HY-136506-1mg
|
MedChemexpress LLC
|
NUC-7738 [CAS 2348493-39-8]
|
|
Cancer-programmed cell death
|
|
HY-136506-10mg
|
MedChemexpress LLC
|
NUC-7738 [CAS 2348493-39-8]
|
|
Cancer-programmed cell death
|
|
HY-136506-5mg
|
MedChemexpress LLC
|
NUC-7738 [CAS 2348493-39-8]
|
|
Cancer-programmed cell death
|
|
HY-11107-10mg
|
MedChemexpress LLC
|
PHA-665752 [CAS 477575-56-7]
|
|
Cancer-Kinase/protease
|
|
HY-11107-100mg
|
MedChemexpress LLC
|
PHA-665752 [CAS 477575-56-7]
|
|
Cancer-Kinase/protease
|
|
HY-11107-25mg
|
MedChemexpress LLC
|
PHA-665752 [CAS 477575-56-7]
|
|
Cancer-Kinase/protease
|
|
HY-11107-5mg
|
MedChemexpress LLC
|
PHA-665752 [CAS 477575-56-7]
|
|
Cancer-Kinase/protease
|
|
HY-11107-50mg
|
MedChemexpress LLC
|
PHA-665752 [CAS 477575-56-7]
|
|
Cancer-Kinase/protease
|
|
HY-11107-1mL
|
MedChemexpress LLC
|
PHA-665752 [CAS 477575-56-7] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
HY-148255-10mg
|
MedChemexpress LLC
|
QN523 [CAS 878581-60-3]
|
|
Cancer-programmed cell death
|
|
HY-148255-100mg
|
MedChemexpress LLC
|
QN523 [CAS 878581-60-3]
|
|
Cancer-programmed cell death
|
|
HY-148255-25mg
|
MedChemexpress LLC
|
QN523 [CAS 878581-60-3]
|
|
Cancer-programmed cell death
|
|
HY-148255-5mg
|
MedChemexpress LLC
|
QN523 [CAS 878581-60-3]
|
|
Cancer-programmed cell death
|
|
HY-148255-50mg
|
MedChemexpress LLC
|
QN523 [CAS 878581-60-3]
|
|
Cancer-programmed cell death
|
|
HY-106161-1mg
|
MedChemexpress LLC
|
Rupintrivir [CAS 223537-30-2]
|
|
COVID-19-anti-virus
|
|
HY-106161-10mg
|
MedChemexpress LLC
|
Rupintrivir [CAS 223537-30-2]
|
|
COVID-19-anti-virus
|
|
HY-106161-5mg
|
MedChemexpress LLC
|
Rupintrivir [CAS 223537-30-2]
|
|
COVID-19-anti-virus
|
|
HY-106161-1mL
|
MedChemexpress LLC
|
Rupintrivir [CAS 223537-30-2] (10mM in DMSO)
|
|
COVID-19-anti-virus
|
|
HY-144898-10mg
|
MedChemexpress LLC
|
SB-216 [CAS 2756818-39-8]
|
|
Cancer-programmed cell death
|
|
HY-144898-100mg
|
MedChemexpress LLC
|
SB-216 [CAS 2756818-39-8]
|
|
Cancer-programmed cell death
|
|
HY-144898-25mg
|
MedChemexpress LLC
|
SB-216 [CAS 2756818-39-8]
|
|
Cancer-programmed cell death
|
|
HY-144898-5mg
|
MedChemexpress LLC
|
SB-216 [CAS 2756818-39-8]
|
|
Cancer-programmed cell death
|
|
HY-144898-50mg
|
MedChemexpress LLC
|
SB-216 [CAS 2756818-39-8]
|
|
Cancer-programmed cell death
|
|
HY-144898-1mL
|
MedChemexpress LLC
|
SB-216 [CAS 2756818-39-8] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-N10265-2500ug
|
MedChemexpress LLC
|
Stephacidin B [CAS 360765-75-9]
|
|
Cancer-programmed cell death
|
|